Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
These findings provide valuable insights into the occurrence of ADEs following the use of eculizumab and could support clinical monitoring and risk identification efforts.
Authors
- Jian-Rong Zhao
- Ruifeng Xu (ORCID: https://orcid.org/0000-0002-4009-5679)
- Yan Meng (ORCID: https://orcid.org/0000-0002-9236-5546)
- Xi-Feng Wang
- Ta‐la Hu
- Shufang Wang
- Jingyuan Wang (ORCID: https://orcid.org/0000-0002-5722-8546)
- Luri Bao
- Wu‐niri Gao
- Zhen-li Fu
Institutions
- Hohhot First Hospital (CN)
- Inner Mongolia Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-01-09
- DOI
- https://doi.org/10.3389/fphar.2024.1440907
- Citations
- 2
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 2.61
Funders
- Inner Mongolia Medical University
- National Natural Science Foundation of China
- Natural Science Foundation of Inner Mongolia
- Peking Union Medical College